pubs.acs.org/joc
chemotypes.7 Yet, many fused bicyclic imidazole systems
Efficient, Regioselective Access to Bicyclic
Imidazo[1,2-x]- Heterocycles via Gold- and
Base-Promoted Cyclization of 1-Alkynylimidazoles
remain un- or under-explored.6b
One promising approach to the rapid elaboration of a wide
variety of fused bicyclic imidazo[1,2-x] heterocycles, having
a bridgehead imidazole nitrogen atom, focuses on the cycli-
zation reactions of the relatively unexplored 1-alkynylimi-
dazoles.8 We recently reported a coupling reaction between
imidazoles and bromoalkynes mediated by copper com-
plexes allowing access to a wide range of these compounds.9
The further functionalization of those 1-alkynylimidazoles
at the 2 position by formation of their 2-lithio derivatives and
subsequent treatment with various electrophiles has been
studied.10 The cyclization of 1-alkynylimidazoles containing
appropriate nucleophilic groups at their 2 position can
afford two types of bicyclic imidazoles depending upon the
regiochemistry of the cyclization (Figure 1). Of particular
interest is the degree to which the ynamine-like chemistry of
the imidazole-substituted alkyne group plays a role in bias-
ing the regiochemistry of this cyclization as well as the
potential to control the regiochemistry by reagent selection
using transition metals to activate the alkyne π-system.11
In exploring the 2-functionalization of the 1-alkynylimi-
dazole 1a by deprotonation and trapping of the anion with
Christophe Laroche and Sean M. Kerwin*
Division of Medicinal Chemistry, College of Pharmacy and
Department of Chemistry, The University of Texas at Austin,
Austin, Texas 78712
Received October 1, 2009
(4) For recent examples, see: (a) Kim, P.; Kang, S.; Boshoff, H. I.; Jiricek,
J.; Collins, M.; Singh, R.; Manjunatha, U. H.; Niyomrattanakit, P.; Zhang,
L.; Goodwind, M.; Dick, T.; Keller, T. H.; Dowd, C. S.; Barry, C. E. J. Med.
Chem. 2009, 52, 1329–1344. (b) Thompson, A. M.; Blasser, A.; Anderson, R.
F.; Shinde, S .S.; Franzblau, S. G.; Ma, Z.; Denny, W. A.; Palmer, B. D.
J. Med. Chem. 2009, 52, 637–545. (c) Wu, J.-P.; Emeigh, J.; Gao, D. A.;
Goldberg, D. R.; Kuzmich, D.; Miao, C.; Potocki, I.; Qian, K. C.; Sorcek, R.
J.; Jeanfavre, D. D.; Kishimoto, K.; Mainolfi, E. A.; Nabozny, G., Jr.; Peng,
C.; Reilly, P.; Rothlein, R.; Sellati, R. H.; Woska, J. R., Jr.; Chen, S.; Gunn,
J. A.; O’Brien, D.; Norris, S. H.; Kelly, T. A. J. Med. Chem. 2007, 47, 5356–
5366. (d) Gehlert, D. R.; Cippitelli, A.; Thorsell, A.; Le, A.-D.; Hipskind, P.
A.; Hamdouchi, C.; Lu, J.; Hembre, E. J.; Cramer, J.; Song, M.; McKinzie,
D.; Morin, M.; Ciccocioppo, R.; Helig, M. J. Neurosci. 2007, 27, 2718–2726.
(e) Enguehard-Gueiffier, C.; Gueiffier, A. Mini-Rev. Med. Chem. 2007, 7, 88–
899. (f) Miwa, S.; Mizokami, A.; Keller, E. T.; Taichman, R.; Zhang, J.;
Namiki, M. Cancer Res. 2005, 65, 8818–8825. (g) Dubuisson, M. L. N.; Ress,
J.-F.; Marchand-Brynaert, J. Drug Dev. Ind. Pharm. 2005, 31, 827–849.
(h) Chimirri, A.; Monforte, P.; Rao, A.; Zappala, M.; Monforte, A. M.; De
Sarro, G.; Pannecouque, C.; Witvrouw, M.; Balzarini, J.; De Clercq, E.
Antiviral Chem. Chemother. 2001, 12, 169–174.
Reactions of 1-alkynylimidazoles involving the forma-
tion of their 2-lithio derivatives followed by addition of
aldehydes or ketones are presented. The method gives
access to 1-alkynyl-2-(hydroxymethyl)imidazoles which
undergo 6-endo-dig or 5-exo-dig cyclization under AuCl3-
or base-catalyzed conditions to yield imidazo[1,2-c]-
oxazoles and imidazo[2,1-c][1,4]oxazine heterocycles.
Under transition metal catalysis, the reaction occurs in
a regiospecific manner, leading exclusively to the product
of 6-endo-dig attack, whereas under basic conditions, the
reaction takes place in a regioselective manner giving
preferentially the product from 5-exo-dig attack.
(5) (a) Harrison, T. S.; Keating, G. M. CNS Drugs 2005, 19, 65–89. (b)
Basiuk, V. A. Russ. Chem. Rev. 1997, 66, 187–204. (d) Ansini, M.; Cappelli,
A.; Vomero, S.; Giorgi, G.; Langer, T.; Bruni, G.; Romeo, R.; Basile, A. S.
J. Med. Chem. 1996, 39, 4275–4284. (c) Heeres, J.; Backx, L. J. J.; Mostmans,
J. H.; Vancutsem, J. J. Med. Chem. 1979, 22, 1003–1005.
(6) (a) Preston, P. N. Condensed Imidazoles: 5-5 Ring Systems; Wiley: New
York, 1986; pp 1-46. (b) Hulme, C.; Lee, Y.-S. Mol. Diversity 2008, 12, 1–15. (c)
Nodwell, M.; Pereira, A.; Riffell, J. L.; Zimmerman, C.; Patrick, B. O.; Roberge,
M.; Andersen, R. J. J. Org. Chem. 2009, 74, 995–1006. (d) Allin, S. M.; Barton,
W. R. S.; Bowman, W. R.; Bridge, E.; Elsegood, M. R. J.; McInally, T.; McKee, V.
Tetrahedron 2008, 64, 7745–7758. (e) Lovely, C. J.; Du, H.; Sivappa, R.;
Bhandari, M. R.; He, Y.; Dias, H. V. R. J. Org. Chem. 2007, 72, 3741–3749.
(f) Chen, Y.; Dias, H. V. R.; Lovely, C. J. Tetrahedron Lett. 2003, 44, 1379–1382.
(g) Hua, D. H.; Zhang, Z.; Chen, J. J. Org. Chem. 1994, 59, 5084–5087.
(7) (a) Krasavin, M.; Shkavrov, S.; Parchinsky, V.; Bukhryakov, K.
J. Org. Chem. 2009, 74, 2627–2629. (b) Nowak, J.; Skalski, B.; Gdaniec,
Z.; Milecki, J. Tetrahedron Lett. 2009, 50, 1671–1673. (c) Nayak, M.;
Kanojiya, S.; Batra, S. Synthesis 2009, 431–437. (d) Gracias, V.; Gasiecki,
A. F.; Djuric, S. W. Org. Lett. 2005, 7, 3183–3186. (e) Le Bas, M.-D. H.;
O’Shea, D. F. J. Comb. Chem. 2005, 7, 947–951.
Imidazoles are an extremely important class of com-
pounds with applications across all areas of chemistry,1
biology,2 and material science.3 In particular, fused bicyclic
imidazoles, both naturally occurring and synthetic, display a
wide range of biological activities4 and are found in a number
of clinically important drugs.5 There has been a growing
interest in methods to efficiently access known fused imida-
zole frameworks6 and to explore previously unreported
(1) (a) Grimmett, M. R. Imidazole and Benzimidazole Synthesis; Academic
Press: New York, 1997; pp 1-143. (b) Bellina, F.; Cauteruccio, S.; Rossi, R.
Tetrahedron 2007, 63, 4571–4624.
(2) For review, see: De Luca, L. Curr. Med. Chem. 2006, 13, 1–23.
(3) (a) Moylan, C. R.; Miller, R. D.; Twieg, R. J.; Betterton, K. M.; Lee,
V. Y.; Matray, T. J.; Nguyen, C. Chem. Mater. 1993, 5, 1499–1508.
(b) Arduengo, A. J.; Krafczyk, R.; Schmutzler, R.; Craig, H. A.; Goerlich,
J. R.; Marshall, W. J.; Unverzagt, M. Tetrahedron 1999, 55, 14523–14534.
(8) For cyclizations of 1,2-dialkynylimidazoles to imidazo[1,2-
a]pyridines, see: Nadipuram, A.; Kerwin, S. M. Tetrahedron 2006, 62,
3798–3808.
(9) Laroche, C.; Li, J.; Freyer, M. W.; Kerwin, S. M. J. Org. Chem. 2008,
73, 6462–6465.
(10) Laroche, C.; Kerwin, S. M. Tetrahedron Lett. 2009, 50, 5194–5197.
DOI: 10.1021/jo902073m
r
Published on Web 11/09/2009
J. Org. Chem. 2009, 74, 9229–9232 9229
2009 American Chemical Society